Table 5.

Multiple comparisons of the mean values at the end of follow up in all intervention groups in individuals with patients.

Blood biochemistry		HP (n = 23)	Δ	MP (n = 24)	Δ	LP (n = 24)	Δ	Value of p
Serum TC (mmol/L)	Baseline	6.567 ± 0.914		6.124 ± 0.889		6.711 ± 1.104		0.220
	Final	6.562 ± 1.064	−0.004 ± 1.042	5.703 ± 0.887	5.703 ± 0.887	5.843 ± 0.596	−0.868 ± 1.140	0.002
	Value of p	0.984*		0.041*		0.001*		0.023#
Serum TG (mmol/L)	Baseline	2.111 ± 0.827		1.933 ± 1.019		2.332 ± 0.737		0.186
	Final	2.169 ± 0.834	0.058 ± 0.694	1.461 ± 0.748	1.461 ± 0.748	1.741 ± 0.617	−0.591 ± 0.573	0.006
	Value of p	0.691*		0.003**		0.001**		0.003##
Serum HDL (mmol/L)	Baseline	1.433 ± 0.328		1.433 ± 0.328		1.391 ± 0.308		0.389
	Final	1.316 ± 0.313	−0.117 ± 0.253	1.500 ± 0.254	1.500 ± 0.254	1.360 ± 0.354	−0.031 ± 0.211	0.109
	Value of p	0.038*		0.029*		0.476*		0.002#
Serum LDL (mmol/L)	Baseline	4.137 ± 0.685		3.832 ± 0.758		4.180 ± 0.880		0.356
	Final	4.180 ± 0.880	−0.083 ± 0.500	3.661 ± 0.744	3.661 ± 0.744	3.950 ± 0.788	−0.230 ± 0.888	0.165
	Value of p	0.406*		0.045**		0.218**		0.745#
Plasma glucose (mmol/L)	Baseline	5.66 ± 0.66		5.69 ± 0.55		5.85 ± 0.51		0.318
	Final	5.80 ± 0.57	0.14 ± 0.45	5.72 ± 0.58	5.72 ± 0.58	5.83 ± 0.53	−0.03 ± 0.23	0.769
	Value of p	0.159*		0.759*		0.572*		0.329#
Plasma uric acid (mmol/L)	Baseline	314.46 ± 26.49		300.40 ± 25.37		307.28 ± 27.66		0.116
	Final	315.03 ± 23.45	0.57 ± 29.67	303.32 ± 30.92	303.32 ± 30.92	309.68 ± 25.31	2.41 ± 20.41	0.330
	Value of p	0.927**		0.425*		0.569*		0.935##

HP group: High proportion of n6/n3 group (n6/n3 = 7.5/1). MP group: Middle proportion of n6/n3 group (n6/n3 = 2.5/1). LP group: Low proportion of n6/n3 group (n6/n3 = 1/2.5). Δ: delta (final value – after intervention value). *Student’s t test, paired. **Wilcoxon test. ^#One-way ANOVA. ^##Kruskal-Wallis.